Type of desmin expression in cardiomyocytes - a good marker of heart failure development in idiopathic dilated cardiomyopathy

Journal of Internal Medicine

Volumn 272, Issue 3, 2012, Pages 287-297

  Pawlak, A ^a   Gil, R J ^a,b   Kulawik, T ^a   Pronicki, M ^c   Karkucinska Wieogonekckowska A ^c   Szymanska Deogonekbinska T ^c   Gil, K ^a   Lagwinski, N ^d   Czarnowska, E ^c  

^a CENTRAL CLINICAL HOSPITAL OF THE MINISTRY OF INTERIOR   (Poland)

^b MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

^c CHILDREN'S MEMORIAL HEALTH INSTITUTE   (Poland)

^d Fresno Heart Hospital Community Medical Centers of Central California   (United States)

Author keywords

Brain natriuretic peptide; Echocardiography; Heart failure; Molecular biology; Nyha

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; DESMIN;

ADULT; ARTICLE; CONGESTIVE CARDIOMYOPATHY; CYTOSKELETON; DISEASE COURSE; DISEASE MARKER; FEMALE; FIBROSIS; HEART FAILURE; HEART FUNCTION; HEART HYPERTROPHY; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART MUSCLE BIOPSY; HEART MUSCLE CELL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MITOCHONDRION; PRIORITY JOURNAL; PROTEIN EXPRESSION; ULTRASTRUCTURE;

BIOLOGICAL MARKERS; BIOPSY; CARDIOMYOPATHY, DILATED; DESMIN; DIASTOLE; ENDOCARDIUM; FEMALE; FIBROSIS; HEART FAILURE; HUMANS; IMMUNOHISTOCHEMISTRY; LINEAR MODELS; MALE; MICROSCOPY, ELECTRON; MIDDLE AGED; MITOCHONDRIA; MYOCYTES, CARDIAC; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; STAINING AND LABELING; STROKE VOLUME;

EID: 84865530600     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2012.02524.x     Document Type: Article

References (28)

1. Osadchii OE, Norton GR, McKechnie R, Deftereos D, Woodiwiss AJ. Cardiac dilatation and pump dysfunction without intrinsic myocardial systolic failure following chronic beta-adrenoreceptor activation. Am J Physiol Heart Circ Physiol 2007; 292: H1898-905.
2. Monreal G, Nicholson LM, Han B et al. Cytoskeletal remodeling of desmin is more accurate measure of cardiac dysfunction than fibrosis or myocyte hypertrophy. Life Sci 2008; 83: 786-94.
3. Schaper J, Froede R, Hein S et al. Impairment of the myocardial ultrastructure and changes of the cytoskeleton in dilated cardiomyopathy. Circulation 1991; 83: 504-14.
4. Di Somma S, Marotta M, Salvatore G et al. Changes in myocardial cytoskeletal intermediate filaments and myocyte contractile dysfunction in dilated cardiomyopathy: an in vivo study in humans. Heart 2000; 84: 659-67.
5. Di Somma S, Di Benedetto MP, Salvatore G et al. Desmin-free cardiomyocyte and myocardial dysfunction in end stage heart failure. Eur J Heart Fail 2004; 6: 389-98.
6. Heling A, Zimmermann R, Kostin S et al. Increased expression of cytoskeletal, linkage, and extracellular proteins in failing human myocardium. Circ Res 2000; 86: 846-53.
7. Tolstonog GV, Sabasch M, Traub P. Cytoplasmic intermediate filaments are stably associated with nuclear matrices and potentially modulate their DNA-binding function. DNA Cell Biol 2002; 21: 213-39.
8. Lazarides E. Intermediate filaments as mechanical integrators of cellular space. Nature 1980; 283: 249-56.
9. Schrickel JW, Stöckigt F, Krzyzak W et al. Cardiac conduction disturbances and differential effects on atrial and ventricular electrophysiological properties in desmin deficient mice. J Interv Card Electrophysiol 2010; 28: 71-80.
10. Milner DJ, Taffet GE, Wang X et al. The absence of desmin leads to cardiomyocyte hypertrophy and cardiac dilation with compromised systolic function. J Mol Cell Cardiol 1999; 31: 2063-76.
11. Wang X, Osinska H, Dorn 2nd GW et al. Mouse model of desmin-related cardiomyopathy. Circulation 2001; 103: 2402-7.
12. Pawlak A, Gil RJ, Walczak E, Seweryniak P. Desmin expression in human cardiomyocytes and selected clinical and echocardiographic parameters in patients with chronic heart failure. Kardiol Pol 2009; 67: 955-61. PMID: 19838951
13. Pawlak A, Gil RJ, Kasprzak J, Walczak E, Slysz A. Cardiomyocyte desmin abnormalities - an accurate predictor of long-term survival in patients with chronic heart failure. Kardiol Pol 2009; 67: 724-33. PMID: 19649994.
14. Evangelista A, Flachskamp F, Lancellotti P et al. European Association of Echocardiography recommendations for standardization of performance, digital storage and reporting of echocardiographic studies. Eur J Echocardiogr 2008; 9: 438-48.
15. Kostin S, Hein S, Arnon E, Scholz D, Schaper J. The cytoskeleton and related proteins in the human failing heart. Heart Fail Rev 2000; 5: 271-80.
16. Collins JF, Pawloski-Dahm C, Davis MG, Ball N, Dorn 2nd GW, Walsh RA. The role of the cytoskeleton in left ventricular pressure overload hypertrophy and failure. J Mol Cell Cardiol 1996; 28: 1435-43.
17. Diguet N, Mallat Y, Ladouce R et al. Muscle creatine kinase deficiency triggers both actin depolymerization and desmin disorganization by advanced glycation end products in dilated cardiomyopathy. J Biol Chem 2011; 286: 35007-19.
18. Aquila LA, McCarthy PM, Smedira NG, Young JB, Moravec CS. Cytoskeletal structure and recovery in single human cardiac myocytes. J Heart Lung Transplant 2004; 23: 954-63.
19. Maloyan A, Sanbe A, Osinska H et al. Mitochondrial dysfunction and apoptosis underlie the pathogenic process in alpha-B-crystallin desmin-related cardiomyopathy. Circulation 2005; 112: 3451-61.
20. Jarreta D, Orus J, Barrientos A et al. Mitochondrial function in heart muscle from patients with idiopathic dilated cardiomyopathy. Cardiovasc Res 2000; 45: 860-5.
21. Kallwellis-Opara A, Staudt A, Trimert C et al. Immunoadsorption and subsequent immunoglobulin substitution decreases myocardial gene expression of desmin in dilated cardiomyopathy. J Mol Med 2007; 85: 1429-35.
22. Su H, Wang X. The ubiquitin-proteasome system in cardiac proteinopathy: a quality control perspective. Cardiovasc Res 2010; 85: 253-62. Epub 2009 Aug 20.
23. Capetanaki Y, Milner DJ, Weitzer G. Desmin in muscle formation and maintenance: knockouts and consequences. Cell Struct Funct 1997; 22: 103-16.
24. Thornell L, Carlsson L, Li Z, Mericskay M, Paulin D. Null mutation in the desmin gene gives rise to a cardiomyopathy. J Mol Cell Cardiol 1997; 29: 2107-24.
25. Fountoulakis M, Soumaka E, Rapti K et al. J Mol Cell Cardiol 2005; 38: 461-74.
26. Lindén M, Li Z, Paulin D, Gotow T, Leterrier JF. Effects of desmin gene knockout on mice heart mitochondria. J Bioenerg Biomembr 2001; 33: 333-41.
27. Capetanaki Y. Desmin cytoskeleton: a potential regulator of muscle mitochondrial behavior and function. Trends Cardiovasc Med 2002; 12: 339-48.
28. Tanaka M, Hiroe M, Nishikawa T, Sato T, Marumo F. Cellular localization and structural characterization of natriuretic peptide-expressing ventricular myocytes from patients with dilated cardiomyopathy. J Histochem Cytochem 1994; 42: 1207-14.